Acarbose Tablet
Product Images NDC 23155-148

7 FDA label images from Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acarbose (NDC 23155-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 01

B19003ee Dd84 4104 Bcbc Ce752962aa59 01
Chemical structure of acarbose, illustrating the molecular arrangement of atoms and bonds characteristic of this oral prescription drug used in tablet form by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.*
FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 02

B19003ee Dd84 4104 Bcbc Ce752962aa59 02
A bar graph titled 'Dose of Acarbose tablets (t.i.d)' showing mean change in plasma glucose (mg/dL) on the vertical axis with doses of 25 mg, 50 mg, 100 mg, 200 mg, and 300 mg on the horizontal axis. Each bar includes the sample size (N) for each dose group, illustrating the impact of varying Acarbose doses on plasma glucose levels in study participants.*
FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 03

B19003ee Dd84 4104 Bcbc Ce752962aa59 03
Figure 2 displays four line graphs labeled A to D comparing different treatments over 12 months. Each graph plots variables over time (months) with values ranging from -1.5 to 1.5 on the y-axis. Graph A shows 'Diet,' B 'Sulfonylurea,' C 'Metformin,' and D 'Insulin.' Lines with circles and squares represent different data series in each graph, indicating trends over the 12-month period.*
FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 04

FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 05

B19003ee Dd84 4104 Bcbc Ce752962aa59 05
Packaging label for Acarbose Tablets USP, 25 mg strength, oral tablets in a bottle of 100 count. The label includes storage instructions, manufacturer details (RA Chem Pharma Limited, India), and distributor information (Avet Pharmaceuticals Inc., East Brunswick, NJ). Barcode and batch printing area are also shown.*
FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 06

B19003ee Dd84 4104 Bcbc Ce752962aa59 06
Label for Acarbose Tablets, USP 50 mg oral tablets, 100 count, prescription only. The label includes storage instructions to keep at 20°C to 25°C and protect from moisture, with child-resistant packaging. Manufactured by RA Chem Pharma Limited, distributed by Avet Pharmaceuticals Inc. in East Brunswick, NJ. The label features barcodes and space for batch details and expiration date to be printed at packaging.*
FDA Label Image

B19003ee Dd84 4104 Bcbc Ce752962aa59 07

B19003ee Dd84 4104 Bcbc Ce752962aa59 07
Acarbose Tablets USP 100 mg oral tablets label from Avet Pharmaceuticals Inc. The label includes dosage strength (100 mg), quantity (100 tablets), and manufacturer information (RA Chem Pharma Limited, India). It also presents storage instructions, a barcode, and space for batch-specific details and QR code to be printed at packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.